230 related articles for article (PubMed ID: 17523989)
1. Implicit learning, executive function and hedonic activity in chronic polydrug abusers, currently abstinent polydrug abusers and controls.
Stevens A; Peschk I; Schwarz J
Addiction; 2007 Jun; 102(6):937-46. PubMed ID: 17523989
[TBL] [Abstract][Full Text] [Related]
2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
3. Implicit cognition is impaired and dissociable in a head-injured group with executive deficits.
Barker LA; Andrade J; Romanowski CA; Morton N; Wasti A
Neuropsychologia; 2006; 44(8):1413-24. PubMed ID: 16436286
[TBL] [Abstract][Full Text] [Related]
4. Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls.
Morgan CJ; Muetzelfeldt L; Curran HV
Addiction; 2009 Jan; 104(1):77-87. PubMed ID: 19133891
[TBL] [Abstract][Full Text] [Related]
5. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study.
Morgan CJ; Muetzelfeldt L; Curran HV
Addiction; 2010 Jan; 105(1):121-33. PubMed ID: 19919593
[TBL] [Abstract][Full Text] [Related]
6. Cognitive recovery during and after treatment for volatile solvent abuse.
Dingwall KM; Maruff P; Fredrickson A; Cairney S
Drug Alcohol Depend; 2011 Nov; 118(2-3):180-5. PubMed ID: 21497458
[TBL] [Abstract][Full Text] [Related]
7. Polydrug abusers display impaired discrimination-reversal learning in a model of behavioural control.
Fillmore MT; Rush CR
J Psychopharmacol; 2006 Jan; 20(1):24-32. PubMed ID: 16174667
[TBL] [Abstract][Full Text] [Related]
8. Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
Bedi G; Redman J
Psychol Med; 2008 Sep; 38(9):1319-30. PubMed ID: 18226286
[TBL] [Abstract][Full Text] [Related]
9. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
[TBL] [Abstract][Full Text] [Related]
10. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
Gouzoulis-Mayfrank E; Thimm B; Rezk M; Hensen G; Daumann J
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
[TBL] [Abstract][Full Text] [Related]
11. Implicit and explicit procedural learning in patients recently remitted from severe major depression.
Pedersen A; Küppers K; Behnken A; Kroker K; Schöning S; Baune BT; Rist F; Arolt V; Suslow T
Psychiatry Res; 2009 Aug; 169(1):1-6. PubMed ID: 19595464
[TBL] [Abstract][Full Text] [Related]
12. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
Reay JL; Hamilton C; Kennedy DO; Scholey AB
J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
[TBL] [Abstract][Full Text] [Related]
13. Measuring impairments in memory and executive function in older people using the Revised Cambridge Cognitive Examination.
Kessels RP; Mimpen G; Melis R; Rikkert MG
Am J Geriatr Psychiatry; 2009 Sep; 17(9):793-801. PubMed ID: 19700951
[TBL] [Abstract][Full Text] [Related]
14. Cognitive inhibition and working memory in unipolar depression.
Gohier B; Ferracci L; Surguladze SA; Lawrence E; El Hage W; Kefi MZ; Allain P; Garre JB; Le Gall D
J Affect Disord; 2009 Jul; 116(1-2):100-5. PubMed ID: 19042027
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic ketamine use on frontal and medial temporal cognition.
Chan KW; Lee TM; Siu AM; Wong DP; Kam CM; Tsang SK; Chan CC
Addict Behav; 2013 May; 38(5):2128-32. PubMed ID: 23435274
[TBL] [Abstract][Full Text] [Related]
16. Cognitive impulsivity in cocaine and heroin polysubstance abusers.
Verdejo-García AJ; Perales JC; Pérez-García M
Addict Behav; 2007 May; 32(5):950-66. PubMed ID: 16876962
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy.
Messinis L; Lyros E; Andrian V; Katsakiori P; Panagis G; Georgiou V; Papathanasopoulos P
Hum Psychopharmacol; 2009 Oct; 24(7):524-31. PubMed ID: 19650155
[TBL] [Abstract][Full Text] [Related]
18. Self-reports of executive dysfunction in current ecstasy/polydrug Users.
Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
Cogn Behav Neurol; 2012 Sep; 25(3):128-38. PubMed ID: 22960437
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers.
Verdejo A; Toribio I; Orozco C; Puente KL; Pérez-García M
Drug Alcohol Depend; 2005 Jun; 78(3):283-8. PubMed ID: 15893159
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis.
Verdejo-García AJ; López-Torrecillas F; Aguilar de Arcos F; Pérez-García M
Addict Behav; 2005 Jan; 30(1):89-101. PubMed ID: 15561451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
